Health Care & Life Sciences » Biotechnology | Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
57.99 M
Public Float
29.05 M
Agios Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.99
Market Cap
$2.69 B
Shares Outstanding
58.71 M
Public Float
50.88 M

Profile

Address
88 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.agios.com
Updated 07/08/2019
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. Its product candidates include IDHIFA, ivosidenib, AG-881, AG-348, and AG-270.

Financials

View All

John M. Maraganore
Chairman
David T. Scadden
Independent Director